Modulatory effect of the ovary on LH secretion

Annals of the New York Academy of Sciences

Volumn 997, Issue , 2003, Pages 35-41

  Messinis, Ioannis E ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

Estradiol (E2); Follicle stimulating hormone (FSH); Gonadotropin surge attenuating factor (GnSAF); LH surge; Ovarian steroids; Ovaries; Progesterone

Indexed keywords

ESTRADIOL; GONADOTROPIN; GONADOTROPIN SURGE ATTENUATING FACTOR; LUTEINIZING HORMONE; PROGESTERONE; SERUM ALBUMIN; FOLLITROPIN;

CARBOXY TERMINAL SEQUENCE; CONFERENCE PAPER; FEMALE; FOLLICULAR PHASE; GONADOTROPIN RELEASE; GRANULOSA CELL; HORMONE ACTION; HUMAN; HUMAN CELL; LUTEAL PHASE; LUTEINIZING HORMONE RELEASE; MENSTRUAL CYCLE; MOLECULAR WEIGHT; OVARY FUNCTION; OVULATION; REGULATORY MECHANISM; ADOLESCENT; ADULT; ANIMAL; METABOLISM; MIDDLE AGED; OVARY; PHYSIOLOGY; REVIEW; SECRETION; SENSITIVITY AND SPECIFICITY; SUPEROVULATION;

FALLOPIA;

ADOLESCENT; ADULT; ANIMALS; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; FOLLICULAR PHASE; GONADOTROPINS; HUMANS; LUTEAL PHASE; LUTEINIZING HORMONE; MENSTRUAL CYCLE; MIDDLE AGED; OVARY; OVULATION; SENSITIVITY AND SPECIFICITY; SUPEROVULATION;

EID: 0642364503     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1290.004     Document Type: Conference Paper

References (29)

1. TSAI, C.C. & S.S.C. YEN. 1971. The effect of ethinylestradiol administration during the early follicular phase of the cycle on the gonadotropin levels and ovarian function. J. Clin. Endocrinol. Metab. 33: 917-923.
2. YEN, S.S.C. & C.C. TSAI. 1972. Acute-gonadotropin release induced by exogenous estradiol during the mid-follicular phase of the menstrual cycle. J. Clin. Endocrinol. Metab. 34: 298-305.
3. YOUNG, J.R. & R.B. JAFFE. 1976. Strength-duration characteristics of estrogen effects of gonadotropin response to gonadotropin-releasing hormone in women. II. Effects of varying concentrations of estradiol. J. Clin. Endocrinol. Metab. 42: 432-442.
4. MESSINIS, I.E. & A.A. TEMPLETON. 1990. Effects of supraphysiological concentrations of progesterone on the characteristics of the oestradiol-induced gonadotrophin surge in women. J. Reprod. Fertil. 88: 513-519.
5. MESSINIS, I.E., S. MILINGOS, E. ALEXANDRIS, et al. 2002. Evidence of differential control of FSH and LH responses to GnRH by ovarian steroids in the luteal phase of the cycle. Hum. Reprod. 17: 299-303.
6. MESSINIS, I.E. & A.A. TEMPLETON. 1989. Pituitary response to exogenous LHRH in superovulated women. J. Reprod. Fertil. 87: 633-639.
7. SCHENKEN, R.S. & G.D. HODGEN. 1983. Follicle-stimulating hormone induced ovarian hyperstimulation in monkeys: blockade of the luteinizing hormone surge. J. Clin. Endocrinol. Metab. 57: 50-55.
8. MESSINIS, I.E., A.A. TEMPLETON & D.T. BAIRD. 1985. Endogenous luteinizing hormone surge during superovulation induction with sequential use of clomiphene citrate and pulsatile human menopausal gonadotropin. J. Clin. Endocrinol. Metab. 61: 1076-1080.
9. MESSINIS, I.E. & A.A. TEMPLETON. 1987. Endocrine and follicle characteristics of cycles with and without endogenous luteinizing hormone surges during superovulation induction with pulsatile follicle-stimulating hormone. Hum. Reprod. 2: 11-16.
10. MESSINIS, I.E. & A.A. TEMPLETON. 1991. Evidence that gonadotrophin surge-attenuating factor exists in man. J. Reprod. Fertil. 92: 217-223.
11. SOPELAK, V.M. & G.D. HODGEN. 1984. Blockade of the estrogen-induced luteinizing hormone surge in monkeys: a nonsteroidal antigenic factor in porcine follicular fluid. Fertil. Steril. 41: 108-113.
12. TIO, S., D. KOPPENAAL, C.W. BARDIN & C. Y. CHENG. 1994. Purification of gonadotropin surge-inhibiting factor from Sertoli cell-enriched culture medium. Biochem. Biophys. Res. Commun. 199: 1229-1236.
13. DANFORTH, D.R. & C.Y. CHENG. 1995. Purification of a candidate gonadotropin surge inhibiting factor from porcine follicular fluid. Endocrinology 136: 1658-1665.
14. PAPPA, A., K. SEFERIADIS, TH. FOTSIS, et al. 1999. Purification of a candidate gonadotrophin surge attenuating factor from human follicular fluid. Hum. Reprod. 14: 1449-1456.
15. O'REILLY, M.S., L. HOLMGREN, Y SHING, et al. 1994. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 76: 315-328.
16. O'REILLY, M.S., T. BOEHM, Y. SHING, et al. 1997. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277-285.
17. KARLIGIOTOU, E.A., P. KOLLIA, P.C. PAPAGELLI, et al. 2001. Expression of HSA mRNA in human granulosa cells: further evidence for GnSAF characterization. Hum. Reprod. (Abstr. Book 1), 16: 213.
18. FOWLER, P.A., T. SORSA-LESLIE, P. CASH, et al. 2002. A 60-66 kDa protein with gonadotrophin surge attenuating factor bioactivity produced by human ovarian granulosa cells. Mol. Hum. Reprod 8: 823-832.
19. MESSINIS, I.E. & A.A. TEMPLETON. 1990. In-vivo bioactivity of gonadotrophin surge attenuating factor (GnSAF). Clin. Endocrinol. 33: 213-218.
20. MESSINIS, I.E. & A.A. TEMPLETON. 1991. Attenuation of gonadotrophin release and reserve in superovulated women by gonadotrophin surge attenuating factor (GnSAF). Clin. Endocrinol. 34: 259-263.
21. MESSINIS, I.E., D. LOLIS, L. PAPADOPOULOS, et al. 1993. Effect of varying concentrations of follicle stimulating hormone on the production of gonadotrophin surge attenuating factor (GnSAF) in women. Clin. Endocrinol. 39: 45-50.
22. MESSINIS, I.E., D. LOLIS, K. ZIKOPOULOS, et al. 1994. Effect on an increase in FSH on the production of gonadotrophin-surge-attenuating factor in women. J. Reprod. Fert. 101: 689-695.
23. MESSINIS, I.E., S. MILINGOS, K. ZIKOPOULOS, et al. 1998. Luteinizing hormone response to gonadotrophin-releasing hormone in normal women undergoing ovulation induction with urinary or recombinant follicle stimulating hormone. Hum. Reprod. 13: 2415-2420.
24. WANG, C.F., B.L. LASLEY, A. LEIN & S.S.C. YEN. 1976. The functional changes of the pituitary gonadotrophs during the menstrual cycle. J. Clin. Endocrinol. Metab. 42: 718-728.
25. MESSINIS, I.E., D. LOLIS, K. ZIKOPOULOS, et al. 1996. Effect of follicle stimulating hormone or human chorionic gonadotrophin treatment on the production of gonadotrophin surge attenuating factor (GnSAF) during the luteal phase of the human menstrual cycle. Clin. Endocrinol. 44: 169-175.
26. MESSINIS, I.E., P. HIRSCH & A.A. TEMPLETON. 1991. Follicle stimulating hormone stimulates the production of gonadotrophin surge attenuating factor (GnSAF) in vivo. Clin. Endocrinol. 35: 403-407.
27. MESSINIS, I.E., D. KOUTSOYIANNIS, S. MILINGOS, et al. 1993. Changes in pituitary response to GnRH during the luteal-follicular transition of the human menstrual cycle. Clin. Endocrinol. 38: 159-163.
28. TAYLOR, A.E., H. WHITNEY, J.E. HALL, et al. 1995. Midcycle levels of sex steroids are sufficient to recreate the follicle-stimulating hormone but not the luteinizing hormone midcycle surge: evidence for the contribution of other ovarian factors to the surge in normal women. J. Clin. Endocrinol. Metab. 80: 1541-1547.
29. MESSINIS, I.E., I. PAPAGEORGIOU, S. MILINGOS, et al. 2001. Oestradiol plus progesterone treatment increases serum leptin concentrations in normal women. Hum. Reprod. 16: 1827-1832.